Usp29 - ubiquitin specific peptidase 29 Gene

Also Known as Ocat

Species: Mus musculus

Gene Type: protein coding
Gene ID: 57775

Summary

Predicted to enable cysteine-type endopeptidase activity and thiol-dependent Deubiquitinase. Predicted to be involved in G1/S transition of mitotic cell cycle and protein deubiquitination. Predicted to act upstream of or within proteolysis. Predicted to be active in cytosol and nucleus. Is expressed in several structures, including brain; limb bud; testis; and trunk. Orthologous to human USP29 (ubiquitin specific peptidase 29). [provided by Alliance of Genome Resources, Apr 2022]

Usp29 Products (4)

mRNA Protein Name
NM_001290994.1 NP_001277923.1 ubiquitin carboxyl-terminal hydrolase 29
NM_001360501.1 NP_001347430.1 ubiquitin carboxyl-terminal hydrolase 29
NM_001360502.1 NP_001347431.1 ubiquitin carboxyl-terminal hydrolase 29
NM_021323.3 NP_067298.2 ubiquitin carboxyl-terminal hydrolase 29

Gene Ontology

  • Molecular Function
  • Biological Process
Molecular Function GO Annotation Evidence Références Source
enables cysteine-type endopeptidase activity IDA
IDA: Inferred from direct assay
32457395 MGI
Biological Process GO Annotation Evidence Références Source
involved in defense response to virus IDA
IDA: Inferred from direct assay
32457395 MGI
involved in positive regulation of type I interferon-mediated signaling pathway IDA
IDA: Inferred from direct assay
32457395 MGI
involved in protein K48-linked deubiquitination IDA
IDA: Inferred from direct assay
32457395 MGI
involved in protein stabilization IDA
IDA: Inferred from direct assay
32457395 MGI
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

ubiquitin carboxyl-terminal hydrolase 29

  • ASL1/Usp29 fusion

  • deubiquitinating enzyme 29

  • ossification center-associated transcript

  • ubiquitin thioesterase 29

  • ubiquitin thiolesterase 29

  • ubiquitin-specific-processing protease 29

Related Agents

  • Pre-clinical Phase

Pre-clinical Phase

Bioactive Molecules (3)
Cat. No. Nom du produit
Effect
Pureté
Rare Diseases
HY-RS15539 USP29 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS21077 Usp29 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS27594 Usp29 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Usp29 NCBI NCBI:57663